UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUSQ
1376
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
| $1.87M | ﹤0.01% |
132,594
+9,000
| +7% | +$125K |
|
1377
Sabre
SABR
$838M
| $1.87M | ﹤0.01% |
78,634
+44,734
| +132% | +$1.13M |
|
|
DOC
1378
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.87M | ﹤0.01% |
121,762
+26,035
| +27% | +$431K |
|
1379
Hancock Whitney
HWC
$6.3B
| $1.87M | ﹤0.01% |
58,492
+3,800
| +7% | +$115K |
|
|
MDRX
1380
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.86M | ﹤0.01% |
136,162
+22,000
| +19% | +$297K |
|
|
PRA
1381
DELISTED
ProAssurance
PRA
| $1.86M | ﹤0.01% |
40,210
+2,500
| +7% | +$114K |
|
1382
Booz Allen Hamilton
BAH
$8.65B
| $1.86M | ﹤0.01% |
73,536
+7,369
| +11% | +$200K |
|
1383
InterDigital
IDCC
$8.53B
| $1.85M | ﹤0.01% |
32,541
+1,530
| +5% | +$85.4K |
|
|
KATE
1384
DELISTED
Kate Spade & Company
KATE
| $1.85M | ﹤0.01% |
85,747
+5,100
| +6% | +$148K |
|
|
CAB
1385
DELISTED
Cabela's Inc
CAB
| $1.84M | ﹤0.01% |
36,921
+2,700
| +8% | +$143K |
|
|
HMHC
1386
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.84M | ﹤0.01% |
73,100
+19,000
| +35% | +$471K |
|
1387
Cabot Corp
CBT
$4.36B
| $1.84M | ﹤0.01% |
49,323
+3,400
| +7% | +$147K |
|
|
RKT
1388
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $1.84M | ﹤0.01% |
30,506
-2,254,780
| -99% | -$142M |
|
|
ANAC
1389
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $1.82M | ﹤0.01% |
23,500
+3,500
| +18% | +$229K |
|
1390
Belden
BDC
$5.01B
| $1.82M | ﹤0.01% |
22,399
+1,600
| +8% | +$140K |
|
|
MFA
1391
MFA Financial
MFA
$920M
| $1.82M | ﹤0.01% |
61,474
+5,300
| +9% | +$166K |
|
1392
Guidewire Software
GWRE
$13.3B
| $1.82M | ﹤0.01% |
34,304
+4,305
| +14% | +$222K |
|
1393
Manitowoc
MTW
$512M
| $1.82M | ﹤0.01% |
102,319
+6,513
| +7% | +$119K |
|
1394
Wolverine World Wide
WWW
$1.6B
| $1.81M | ﹤0.01% |
63,696
+9,200
| +17% | +$282K |
|
1395
Penske Automotive Group
PAG
$14.2B
| $1.81M | ﹤0.01% |
34,799
+2,100
| +6% | +$109K |
|
1396
Invesco DB Commodity Index Tracking Fund
DBC
$1.64B
| $1.81M | ﹤0.01% |
100,640
| – | – |
|
|
UIL
1397
DELISTED
UIL HOLDINGS
UIL
| $1.81M | ﹤0.01% |
39,505
+6,700
| +20% | +$333K |
|
1398
Precigen
PGEN
$2.47B
| $1.8M | ﹤0.01% |
37,272
+10,800
| +41% | +$455K |
|
1399
Thor Industries
THO
$4.14B
| $1.8M | ﹤0.01% |
32,012
+6,602
| +26% | +$400K |
|
1400
Nu Skin
NUS
$253M
| $1.8M | ﹤0.01% |
38,173
+2,300
| +6% | +$124K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.